Ariza, Romeo Sr B.
HRN: 27-74-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/24/2025
12/31/2025
IV
250
Q Every Other Day
CAP MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines